![Anju Chatterji](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anju Chatterji currently works at HilleVax, Inc., as Chief Technology Officer from 2023.
Dr. Chatterji also formerly worked at Grifols Biologicals, Inc., as Director-Technical Development and Catalyst Biosciences, Inc., as Senior VP-Biologics Development & Manufacturing.
Dr. Chatterji received her doctorate degree from Indian Agricultural Research Institute.
| Sociétés | Poste | Début |
|---|---|---|
| HILLEVAX, INC. | Directeur Technique/Scientifique/R&D | 01/01/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Grifols Biologicals, Inc.
 Grifols Biologicals, Inc. Pharmaceuticals: MajorHealth Technology Produces protein therapies and products for patients | Directeur Technique/Scientifique/R&D | - |
| CATALYST BIOSCIENCES | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Indian Agricultural Research Institute
 Indian Agricultural Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Grifols Biologicals, Inc.
Grifols Biologicals, Inc. Pharmaceuticals: MajorHealth Technology Produces protein therapies and products for patients | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
HilleVax, Inc.
 HilleVax, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel vaccine candidates | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
